The Role of Endoscopic Interventions in Palliative Care for the Gastrointestinal Tumors

소화기 종양에 대한 내시경적 완화치료

  • Hye Kang Kim (Department of Internal Medicine, The Catholic University of Medicine) ;
  • Dae Young Cheung (Department of Internal Medicine, The Catholic University of Medicine)
  • 김혜강 (가톨릭대학교 의과대학 내과학교실, 소화기내과) ;
  • 정대영 (가톨릭대학교 의과대학 내과학교실, 소화기내과)
  • Received : 2014.05.09
  • Accepted : 2014.05.31
  • Published : 2014.06.30

Abstract

Palliative care for cancer aims to relieve the discomfort and pain from the cancer itself and associated conditions. Gastrointestinal cancers originate from the tube like structure of gastrointestinal tract and cause complications such as obstruction, bleeding, adhesion, invasion, and perforation to adjacent organ. Recent advances in interventional endoscopy enables endoscopy physicians to do safe and effective care for gastrointestinal cancer patients. Endoscopic palliation includes stent, hemostasis, nutritional support and targeted drug delivery. Self expandable metallic stent is one of the most important modalities in gastrointestinal palliation. Through the endoscopy or over the wire pre-placed by endoscopy, stents restore the gastrointestinal luminal patency and relieve the obstructive condition. Endoscopic hemostasis is another important palliation in gastrointestinal cancer patients. Epinephrine injection, argon plasma coagulation and thermal cauterization are usual modalities for hemostasis. Histoacryl glue and fibrin glue are also available. Hemostatic nanopowder spray is newly reported effective in benign disease and is supposed to be effective also in cancer bleeding. Enteral feeding tubes including gastro- or jejunostomy and nosoduodenal tubes are placed by using endoscopic guidance. Enteral feeding tubes role as the route of easily absorbable or semi-digested nutrients and effectively maintain both patients calorie requirements and gut microenvironment. Photodynamic therapy is the one of the outstanding medical employments of photo-physics. Especially for superficial cancers in esophagus, photodynamic therapy is very useful in cancer removal and maintaining organ structure. In biliary neoplasm, photodynamic therapy is well known to be effective in cancer ablation and biliary ductal patency restoration. Targeted drug delivery is the lastest issue in palliative endoscopy. Debates and questions are still on the table. In this article, the role of endoscopic interventions in palliative care for the gastrointestinal tumors will be thoroughly reviewed.

Keywords

References

  1. Hosono S, Ohtani H, Arimoto Y, et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol 2007;42:283-290.
  2. Sheibani S, Kim JJ, Chen B, et al. Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy. Aliment Pharmacol Ther 2013;38:144-150.
  3. Nomura K, Yamada S, Shimizu D, et al. Successful endoscopic hemostasis for gastric arterial bleeding due to invasion of malignant lymphoma. World J Gastroenterol 2005; 11:4285-4286.
  4. Sung JJ, Luo D, Wu JC, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011;43:291-295.
  5. Koh KH, Kim K, Kwon DH, et al. The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer. Gastric Cancer 2013;16:397-403.
  6. Loffroy RF, Abualsaud BA, Lin MD, et al. Recent advances in endovascular techniques for management of acute nonvariceal upper gastrointestinal bleeding. World J Gastrointest Surg 2011;3:89-100.
  7. McCaughan JS, Jr., Hicks W, Laufman L, et al. Palliation of esophageal malignancy with photoradiation therapy. Cancer 1984;54:2905-2910.
  8. Yoon HY, Cheon YK, Choi HJ, et al. Role of photodynamic therapy in the palliation of obstructing esophageal cancer. Korean J Intern Med 2012;27:278-284.
  9. Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2011;60:1449-1472.
  10. Cheon YK, Lee TY, Lee SM, et al. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 2012;14:185-193.
  11. Talreja JP, DeGaetani M, Sauer BG, et al. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment. Photochem Photobiol Sci 2011;10:1233-1238.
  12. Yoo JJ, Kim C, Chung CW, et al. 5-aminolevulinic add-incorporated poly (vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy. Int J Nanomedicine 2012;7:1997-2005.
  13. Jager-Wittenaar H, Dijkstra PU, Vissink A, et al. Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck 2011;33:490-496.
  14. Bhayani MK, Hutcheson KA, Barringer DA, et al. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 2013;35:1634-1640.
  15. Chen AM, Li BQ, Lau DH, et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010;78:1026-1032.
  16. Ha TI, Kim GH, Kang DH, et al. Detection of celiac ganglia with radial scanning endoscopic ultrasonography. Korean J Intern Med 2008;23:5-8.
  17. Levy MJ, Chari ST, Wiersema MJ. Endoscopic ultrasound-guided celiac neurolysis. Gastrointest Endosc Qin N Am 2012;22:231-247.
  18. Pishvaian AC, Collins B, Gagnon G, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006;64:412-417.
  19. Jin Z, Chang BJ. Endoscopic ultrasound-guided fiducial markers and brachytherapy. Gastrointest Endosc Clin N Am 2012;22:325-331.
  20. Chang Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000;88:1325-1335.
  21. Hecht JR, Bedford R, Abbruzzese JL, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003;9:555-561.
  22. Hecht JR, Farrell JJ, Senzer N, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc 2012;75:332-338.